Dr. Vivek Subbiah
Claim this profileMD Anderson Cancer Center
Expert in Cancer
Expert in Solid Tumors
31 reported clinical trials
46 drugs studied
About Vivek Subbiah
Education:
- Obtained a medical degree from Sri Ramachandra Medical College and Research Institute, Chennai, India.
- Completed a combined residency in Internal Medicine and Pediatrics at Case Western Reserve University, MetroHealth, Cleveland, Ohio.
- Pursued fellowships in both adult and pediatric oncology at The University of Texas MD Anderson Cancer Center.
Experience:
- Served nearly 15 years at The University of Texas MD Anderson Cancer Center in various leadership roles, including Associate Professor and Executive Director of Medical Oncology Research.
- Principal investigator in over 100 phase I/II trials, significantly contributing to FDA and international approvals.
- Joined Sarah Cannon Research Institute in 2023 as Chief of Early-Phase Drug Development, leading the expansion of early-phase capabilities.
Area of expertise
1Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Solid Tumors
Global LeaderStage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Vivek Subbiah is currently running
GSK5764227
for Advanced Cancer
The goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of GSK5764227. The study will also see how the levels of GSK5764227 change over time at different dose amounts.
Recruiting1 award Phase 12 criteria
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies
Recruiting1 award Phase 1 & 2
More about Vivek Subbiah
Clinical Trial Related3 years of experience running clinical trials · Led 31 trials as a Principal Investigator · 16 Active Clinical TrialsTreatments Vivek Subbiah has experience with
- Nivolumab
- Pembrolizumab
- Sapanisertib
- Everolimus
- Vandetanib
- Atezolizumab
Breakdown of trials Vivek Subbiah has run
Solid Tumors
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vivek Subbiah specialize in?
Vivek Subbiah focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Vivek Subbiah currently recruiting for clinical trials?
Yes, Vivek Subbiah is currently recruiting for 16 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Vivek Subbiah has studied deeply?
Yes, Vivek Subbiah has studied treatments such as Nivolumab, Pembrolizumab, Sapanisertib.
What is the best way to schedule an appointment with Vivek Subbiah?
Apply for one of the trials that Vivek Subbiah is conducting.
What is the office address of Vivek Subbiah?
The office of Vivek Subbiah is located at: MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.